Thyroid storm induced by combined nivolumab and ipilimumab immunotherapy in advanced non-small cell lung cancer | BMJ Case Reports

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Global health

Authors

About

Help
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Case Reports: Adverse drug reactions and complications

Thyroid storm induced by combined nivolumab and ipilimumab immunotherapy in advanced non-small cell lung cancer

Online download statistics by month:

Online download statistics by month: October 2022 to April 2024

	Abstract	Full	Pdf
Oct 2022	551	559	106
Nov 2022	456	453	41
Dec 2022	131	128	38
Jan 2023	117	116	12
Feb 2023	85	84	17
Mar 2023	59	59	17
Apr 2023	94	91	21
May 2023	97	97	20
Jun 2023	84	83	12
Jul 2023	77	76	15
Aug 2023	91	90	9
Sep 2023	90	88	18
Oct 2023	76	75	13
Nov 2023	81	81	10
Dec 2023	67	69	26
Jan 2024	33	32	11
Feb 2024	78	82	11
Mar 2024	106	102	32
Apr 2024	65	59	16
Total	2438	2424	445